SEC Form 5 · accession 0001140361-18-006690
CytomX Therapeutics, Inc. · CTMX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sean A. McCarthy
Officer — President and CEO · Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 12, 2018 · 6:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001501989
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 7, 2017 | G | 4,500 | $0.00 | D | 154,237 | I | See footnote |
| Common Stock | holding | — | — | — | 4,643 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Held in McCarthy Family Trust dated August 9, 2001, Sean A. McCarthy and Jeanette J. McCarthy, Trustees.